Very obvious that those who bought up shares offered at $1.75 were comfortable buying into the Company's future. So why are we below that price today? Other Institutions purchased shares lately, so why are we below $2.00? I am convinced that we are at the lows and will break out higher when Institutions starts bidding it up.
I quit eating at Red Lobster along with feeding my work crew sometimes 2 times a month, I used to spend around $700 every month. Today , they get ZERO because of cutting meal sizes, and prices going up with less food and no fun there.
Have to agree that it has a lot of potential and this selling is unwarranted. As the company stated, no public offering and could not understand why it dropped, although I was happy to get in at $1.59. I see no bad news ahead and a clear sailing upwards with data to be released in coming weeks. This is a very good buy here and if markets turn it could be a very profitable one. GTLA.
Why would they put the statement " This is not an offer to sell shares" maybe that I am confused of something here? I am reading everywhere that there will be no diluted shares until these e-shares are sold at a later date. Nevertheless, it is a very good buy under 2 bucks for a Cancer drug. After looking at many Cancer drug companies, this seems to be unnoticed and its still in an unknown to many investors.